|

Tenofovir alafenamide Fumarate Clinical Trials

2 actively recruiting trials

Also known as: Vemlidy

Top Sponsors

  • Third Affiliated Hospital, Sun Yat-Sen University1
  • Institute of Liver and Biliary Sciences, India1

Indications

  • Liver Disease2
  • Hepatitis B Virus1
  • Non-cirrhotic, Chronic Hepatitis B1

Other2 trials

Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.
N/A
TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load.
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.